Skip to main content


Cori Gray, PharmD; Catherine E. Cooke, PharmD, MS (PHSR), BCPS, PAHM; Nicole Brandt, PharmD, MBA, BCPP, BCGP, FASCP
Successes and Challenges of the Medicare Part D MTM Program
Jack E. Fincham, PhD, RPh
Sergio I. Prada, MPA, PhD; Johan S. Loaiza, BS
Xiaomeng Yue, BPharm, MS; Jeff Jianfei Guo, BPharm, MS, PhD; Patricia R. Wigle, PharmD
The Importance and Benefits of Smoking-Cessation Therapy
Jack E. Fincham, PhD, RPh
Sergio I. Prada, MPA, PhD
Is the Federal Drug Utilization Review Requirement Just Red Tape or an Enlightened State of Flexibility?
Michael Kleinrock
Health Plan Subsidies, Prescription Drugs, and Cost
Implementing Payment Reform in Oncology: Benefits and Challenges
Patient-Reported Outcomes in Oncology: Challenges and Opportunities for All Stakeholders
Is It Time to Revisit Medicare Part D?
Financing Drug Innovation: Cost versus Cure
Page 1 of 4
Results 1 - 10 of 40